Company Filing History:
Years Active: 2020
Title: Diane E Peters: Innovator in Cancer Treatment
Introduction
Diane E Peters is a notable inventor based in Grafton, MA (US). She has made significant contributions to the field of medical research, particularly in the area of cancer treatment. Her innovative work has led to the development of a unique protective antigen related to anthrax toxin.
Latest Patents
Diane E Peters holds 1 patent for her invention titled "Modified anthrax toxin protective antigen." This patent discloses a protective antigen (PA) comprising a PA amino acid sequence, wherein one or more of the amino acid residues I207, I210, E654, I656, R659, M662, Y681, and L687 are substituted. The invention includes the proviso that amino acid residue I207 is not substituted with alanine and amino acid residue I210 is not substituted with alanine. Additionally, the patent covers related compositions, nucleic acids, recombinant expression vectors, host cells, populations of cells, methods of treating or preventing cancer in a mammal, and methods of inhibiting the growth of a target cell.
Career Highlights
Diane E Peters is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this prestigious institution has allowed her to focus on groundbreaking research that has the potential to impact cancer treatment significantly.
Collaborations
Diane has collaborated with esteemed colleagues such as Shi-Hui Liu and Stephen H Leppla. These partnerships have fostered an environment of innovation and have contributed to the advancement of her research.
Conclusion
Diane E Peters is a pioneering inventor whose work in developing modified anthrax toxin protective antigens showcases her commitment to advancing medical science. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire future research.